Liening D A, Duncan N O, Blakeslee D B, Smith D B
Department of Otolaryngology-Head and Neck Surgery, Madigan Army Medical Center, Tacoma, WA 98431-5000.
Otolaryngol Head Neck Surg. 1990 Jul;103(1):10-3. doi: 10.1177/019459989010300102.
Hypothyroidism is not commonly considered a complication of radiotherapy for head and neck cancer. A series of 96 patients treated with radiotherapy alone or combined with surgery for head and neck cancer was retrospectively studied. All patients had radiation ports that included the thyroid gland. Hypothyroidism after radiotherapy was documented in 26% of all patients. The majority of patients had subclinical hypothyroidism manifested by elevated thyroid-stimulating hormone (TSH) levels. The incidence of hypothyroidism dramatically increased to 65% when radiotherapy was combined with surgery that included a partial thyroidectomy. In addition, we report the unusual occurrence of massive head, neck, and hypopharyngeal edema caused by severe hypothyroidism in two patients. We advocate routine monitoring of head and neck cancer patients for hypothyroidism after radiotherapy involving the thyroid gland and recommend levothyroxine replacement therapy for subclinical hypothyroidism.
甲状腺功能减退通常不被视为头颈癌放疗的并发症。对96例接受单纯放疗或放疗联合手术治疗的头颈癌患者进行了回顾性研究。所有患者的放疗野均包括甲状腺。在所有患者中,26%在放疗后出现甲状腺功能减退。大多数患者表现为亚临床甲状腺功能减退,促甲状腺激素(TSH)水平升高。当放疗联合包括部分甲状腺切除术的手术时,甲状腺功能减退的发生率急剧上升至65%。此外,我们报告了两名患者因严重甲状腺功能减退导致头颈部和下咽严重水肿的罕见情况。我们主张对接受涉及甲状腺的放疗后的头颈癌患者进行甲状腺功能减退的常规监测,并建议对亚临床甲状腺功能减退患者进行左甲状腺素替代治疗。